PL-1
"Chirality Role in Drug Discovery and Development as Studied by
Circular Dichrosm"
Carlo Bertucci
University of Bologna
PL-2
"Atropisomerism in Drug Design;Effects on
Neurokinin 1 Antagonists for Depression"
Jeffrey S. Albert
AstraZeneca Pharmaceuticals
PL-3
"Homochirality, the Signature of Life"
Meir Lahav
The Weizmann Institute of Science
PL-4
"Chirality-the Origin of Biomolecular Asymmetry"
Uwe J. Meierhenrich
University of Nice-Sophia Antipolis
PL-5
"Discovery of the Chiral Clinical Candidate UK-396082:
A Potential Treatment for Thrombosis"
Dafydd Owen
Phizer Global Research and Development
PL-6
"Synthesis and SAR Studies of Marine Cyclic Peptides and Alkaloids"
Dawei Ma
Shanghai Institute of Organic Chemistry
PL-7
"Antibodies as Binders of Chiral Molecules"
Juha Rouvinen
University of Joensuu
PL-8
"Clinical Relevance of Stereoselective Metabolism and Disposition of
Proton Pump Inhibitors: Comparison of Lansoprazole to Omeprazole"
Jae-Gook Shin
Inje University